Cargando…
Intravenous C16 and angiopoietin-1 improve the efficacy of placenta-derived mesenchymal stem cell therapy for EAE
The placenta has emerged as an attractive source of mesenchymal stem cells (MSCs) because of the absence of ethical issues, non-invasive access, and abundant yield. However, inflammatory cell invasion into grafts negatively impacts the survival and efficacy of transplanted cells. Previous studies ha...
Autores principales: | Tian, Ke-wei, Zhang, Yuan-yuan, Jiang, Hong, Han, Shu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854598/ https://www.ncbi.nlm.nih.gov/pubmed/29545630 http://dx.doi.org/10.1038/s41598-018-22867-9 |
Ejemplares similares
-
Author Correction: Intravenous C16 and angiopoietin-1 improve the efficacy of placenta-derived mesenchymal stem cell therapy for EAE
por: Tian, Ke-wei, et al.
Publicado: (2020) -
The differentiation of human placenta-derived mesenchymal stem cells into dopaminergic cells in vitro
por: Chen, Li, et al.
Publicado: (2009) -
Efficacy of Gene Modification in Placenta-Derived Mesenchymal Stem Cells Based on Nonviral Electroporation
por: Kim, Jae Yeon, et al.
Publicado: (2020) -
Improved osteogenesis and upregulated immunogenicity in human placenta-derived mesenchymal stem cells primed with osteogenic induction medium
por: Fu, Xuejie, et al.
Publicado: (2016) -
Mesenchymal Stem Cells Attenuated Blood-Brain Barrier Disruption via Downregulation of Aquaporin-4 Expression in EAE Mice
por: Liu, Yanqun, et al.
Publicado: (2020)